StockData
McKesson Corp logo

McKesson Corp (MCK) company profile

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1084.43−7.24 (-0.66%)

Close on Nov 18, 2026Market cap $126.43BP/E 29.0Yield 0.29%

About McKesson

Wholesale-Drugs, Proprietaries & Druggists' Sundries, SIC 5122

McKesson Corporation is an enterprise involved in healthcare distribution and support services. Operating across distinct operating segments including North American Pharmaceutical, Medical-Surgical Solutions, Oncology and Multispecialty, and Prescription Technology Solutions, the company supplies pharmaceuticals, medical-surgical products, and specialized technology infrastructure. Its operations serve broad healthcare customers through established provider networks, distribution channels, and integrated care solutions across multiple clinical disciplines.

The text indicates business presence across North America and several international jurisdictions, citing operational activities and tax affiliations in Canada, the United Kingdom, Germany, and Luxembourg. The report details physical property, equipment, and network assets across domestic and overseas sites, alongside historical retail operations in Canada and Norway. The provided filing text does not disclose the city or state of the company's headquarters.

Summary of the business section of McKesson's latest annual report, written by StockData.

Company profile

Company

Legal name
McKesson Corp
Founded
1833
Headquarters
Irving, TX
Address
6555 State Highway 161 75039
Phone
(972) 446-4800
Employees
43,000, Mar 31, 2026
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Incorporated in
Delaware
Fiscal year ends
March 31
Auditor
Deloitte & Touche LLP, Dallas, Texas

Stock & identifiers

Ticker
MCK
Exchange
NYSE
IPO date
Nov 10, 1994
Shares outstanding
117M, Jul 31, 2026
Public float
$95.30B, Sep 30, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Jan 5, 1998
SEC CIK
927653
CUSIP
58155Q103
ISIN
US58155Q1031
FIGI
BBG000DYGNW7
Share class FIGI
BBG001S8F8P8
LEI
549300WZWOM80UCFSF54
EIN
94-3207296

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Brian S. TylerChief Executive Officer, Director6,135
Francisco FragaEVP, CIO and CTO4,414
Napoleon B. Rutledge JRSVP, Controller & CAO521
Ramesh (NMN) SrinivasanEVP and Chief Strategy Officer11,959
Thomas L. RodgersEVP, Chief Strategy & BDO2,268
LeAnn B. SmithEVP & Chief HR Officer4,798
Kenny K. CheungEVP & CFO–
Michele LauEVP and Chief Legal Officer3,386
Britt J. VitaloneEVP & CFO22,506
Bradley E. LermanDirector0
Kathleen Wilson-ThompsonDirector578
Kevin M. OzanDirector15
Lynne M. DoughtieDirector–
Deborah DunsireDirector–
Maria MartinezDirector578
Webster Roy DunbarDirector–
James H. HintonDirector–
Julie L. GerberdingDirector–
Dominic J. CarusoDirector927
Donald R. KnaussDirector2,069

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026$24.21M$48.93M$5.49M$456$137
FY2025$20.16M$39.17M$4.96M$353$134
FY2024$19.00M$51.71M$5.20M$281$133
FY2023$20.22M$38.81M$4.90M$185$115
FY2022$18.15M$65.28M$4.51M$158$119
FY2021$14.84M$33.05M$4.27M$146$134

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2026

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Brian S. Tyler
Chief Executive Officer
$1.59M$17.20M$4.46M$963.51K$24.21M+20%
Britt J. Vitalone
Executive Vice President and Chief Financial Officer
$1.06M$5.60M$1.86M$209.82K$8.74M+14%
Michele Lau
Executive Vice President and Chief Legal Officer
$766.58K$3.65M$1.07M$104.87K$5.60M+7%
LeAnn B. Smith
Executive Vice President and Chief Human Resources Officer
$693.83K$2.50M$971.37K$87.93K$4.25M+14%
Thomas L. Rodgers
Executive Vice President and Chief Strategy and Business Development Officer
$647.45K$1.75M$906.43K$81.97K$3.39M+5%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of March 31, 2026, we had more than 43,000 employees worldwide, which includes 1,400 part-time employees.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?